Recommended Free Tools
A compound associated with bee propolis has been tested as an antimicrobial ingredient in acrylic bone cement. In a 2015 study, Hye Sun Lee and Jeong Ho Chang compared polymethyl methacrylate (PMMA) cement loaded with caffeic acid phenethyl ester (CAPE) against gentamicin-loaded cement. The laboratory and animal assessments are promising experimental findings—not proof of a human treatment, a cleared medical product, or a cement currently available to hospitals.
What does bee propolis have to do with bone cement?
PMMA is a common acrylic bone cement used to secure orthopedic implants. The compound at the center of this study, caffeic acid phenethyl ester (CAPE), is described by the Royal Society of Chemistry (RSC) as an active component associated with bee propolis. Propolis is a resin-like mixture honey bees collect from trees and buds and use in the hive; it is not a single purified substance.
As an Amazon Associate I earn from qualifying purchases.
The researchers investigated whether CAPE could be incorporated into PMMA cement and retain antimicrobial activity. That is a materials-science question about a particular compound and experimental cement formulation. It does not mean that propolis supplements, ordinary hive propolis, or CAPE taken by mouth can treat an implant infection.
Free tools Windows power users keep installed
One-click scans. No signup required.
How did CAPE-loaded cement compare with gentamicin cement?
Lee and Chang assessed antimicrobial activity against Staphylococcus aureus, a bacterium relevant to implant-associated infection. Their paper reports controlled release of CAPE that varied with time and concentration. The RSC summary explains that the team explored an alternative in light of concerns associated with antibiotic-loaded cement, including resistance and possible effects on mechanical strength; these are the motivation described for the study, not universal conclusions about every antibiotic cement.
#1 Best Overall
| Measure in the reported study | CAPE-loaded PMMA | Gentamicin-loaded PMMA |
|---|---|---|
| Antimicrobial assessment | Tested against S. aureus; authors report antimicrobial activity. | Included as the antibiotic-loaded comparator; the abstract does not give a directly comparable numerical effect size. |
| Release | Controlled release reported, varying with time and concentration. | A directly comparable release result is not stated in the accessible abstract. |
| Compressive strength | Above 130 MPa across the tested formulations, as reported by Lee and Chang (2015). | Above 80 MPa across the tested formulations, as reported by Lee and Chang (2015). |
Those strength figures belong to the formulations and test conditions in this experiment. They are not a general specification for CAPE cement or a clinical result, and the accessible abstract does not provide enough methodological detail to reconstruct the testing independently.
What biological testing was reported?
The abstract lists both in vitro and in vivo assessments. These included antimicrobial effects, cytotoxicity, a bacterial reverse mutation (Ames) assay, a micronucleus assay, and implantation analysis. The authors report positive results in these assessments without an inflammatory response.
The RSC summary says initial studies were carried out in rabbits. The accessible abstract does not provide full protocols, sample sizes, or enough detail to judge long-term safety independently. A set of laboratory and animal tests can help determine whether a material merits further investigation; it cannot establish how well it works or how safe it is in people.
Has CAPE bone cement been shown to work in people?
No human clinical effectiveness is established by the sources describing this study. The RSC summary quotes Chang saying that human clinical application would follow evaluation of therapeutic efficacy. The available sources also do not establish regulatory clearance, clinical adoption, or current commercial availability of CAPE-loaded cement.
The paper by Hye Sun Lee and Jeong Ho Chang was submitted on 24 June 2014, accepted on 31 October 2014, and first published on 3 November 2014. It appeared in MedChemComm, volume 6, issue 2 (2015), pages 327–333. The RSC summary page is dated 23 February 2015 and notes that the story first appeared in Chemistry World in November 2014.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Why is cement only one part of infection prevention?
Antimicrobial materials are only one possible part of preventing infection around orthopedic implants. Biomaterials expert Antoni Tomsia of Lawrence Berkeley National Laboratory emphasized accompanying measures, including “provider hand hygiene, patient decolonisation efforts, or environmental decontamination, plus sterilisation, to prevent infections.” The quotation underscores that an experimental cement formulation should not be treated as a substitute for infection-control practices.
Quick Recap
Sources
- Hye Sun Lee and Jeong Ho Chang, “Caffeic acid phenethyl ester-loaded poly(methyl methacrylate) bone cement for effective antibiotic delivery,” Royal Society of Chemistry, 2015.
- Royal Society of Chemistry summary: “Beehive to bone cement,” 23 February 2015.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
